{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:14:26Z","timestamp":1787004866855,"version":"build-2736575974"},"reference-count":48,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Children with cancer have an increased risk for venous thromboembolic events (VTEs) compared to the healthy pediatric population. VTE rates in children with cancer vary among cancer types. Other VTE risk factors include central venous catheters and cancer therapies. VTE diagnosis relies on objective radiological imaging, and management to this date typically involves anticoagulant therapy. Low-molecular-weight heparins (LMWHs) are the most common choice. Evidence for primary VTE prevention is conflicting, and antithrombin replacement, LMWH, or apixaban have been studied. Recently, direct oral anticoagulants such as rivaroxaban or dabigatran were investigated for VTE treatment, showing promise in efficacy and safety. However, bleeding risks in this population need careful consideration, especially periprocedurally or with treatment-related thrombocytopenia. Prediction tools for VTE require adaptation for pediatric cancer patients. Progress in understanding and managing VTE in children with cancer is significant, with ongoing trials and real-world data contributing to improved strategies.<\/jats:p>","DOI":"10.1055\/a-2407-7914","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T19:19:40Z","timestamp":1733858380000},"page":"158-165","source":"Crossref","is-referenced-by-count":2,"title":["Update on Cancer-Associated Venous Thromboembolism in Children"],"prefix":"10.1055","volume":"45","author":[{"given":"Rahel","family":"Kasteler","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hematology, Immunology, Stem Cell Transplantation and Somatic Gene Therapy, University Children's Hospital Zurich - Eleonore Foundation, Zurich, Switzerland"},{"name":"Pediatric Hematology-Oncology Center, Children's Hospital of Eastern Switzerland, St Gallen, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Albisetti","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hematology, Immunology, Stem Cell Transplantation and Somatic Gene Therapy, University Children's Hospital Zurich - Eleonore Foundation, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bosch","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hematology, Immunology, Stem Cell Transplantation and Somatic Gene Therapy, University Children's Hospital Zurich - Eleonore Foundation, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"issue":"04","key":"ref1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jpeds.2011.03.052","article-title":"Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study","volume":"159","author":"R Tuckuviene","year":"2011","journal-title":"J Pediatr"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"e2021054649","DOI":"10.1542\/peds.2021-054649","article-title":"The continued rise of venous thromboembolism across US children's hospitals","volume":"149","author":"S H O'Brien","year":"2022","journal-title":"Pediatrics"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/pbc.21734","article-title":"Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer","volume":"51","author":"U Athale","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2018.02.150","article-title":"Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia","volume":"165","author":"S Prasca","year":"2018","journal-title":"Thromb Res"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"e26938","DOI":"10.1002\/pbc.26938","article-title":"Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: a prospective evaluation","volume":"65","author":"U H Athale","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpeds.2011.01.005","article-title":"Venous thromboembolism and adolescent and young adult oncology inpatients in US children's hospitals, 2001 to 2008","volume":"159","author":"S H O'Brien","year":"2011","journal-title":"J Pediatr"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pbc.21047","article-title":"Thromboembolism in children with sarcoma","volume":"49","author":"U Athale","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"09","key":"ref8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1055\/s-0038-1668543","article-title":"Thromboembolism incidence and risk factors in children with cancer: a population-based cohort study","volume":"118","author":"M C Pelland-Marcotte","year":"2018","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/blood.2019002260","article-title":"Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children","volume":"135","author":"J Jaffray","year":"2020","journal-title":"Blood"},{"issue":"24","key":"ref10","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1182\/blood-2017-10-811216","article-title":"Can thrombophilia predict recurrent catheter-related deep vein thrombosis in children?","volume":"131","author":"M L Avila","year":"2018","journal-title":"Blood"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE","volume":"83","author":"M Andrew","year":"1994","journal-title":"Blood"},{"issue":"05","key":"ref12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mpd.2001.118192","article-title":"Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands","volume":"139","author":"C H van Ommen","year":"2001","journal-title":"J Pediatr"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1046\/j.1538-7836.2003.00465.x","article-title":"Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome","volume":"1","author":"C H van Ommen","year":"2003","journal-title":"J Thromb Haemost"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2016.05.015","article-title":"Age at cancer diagnosis, non-O blood group and asparaginase therapy are independently associated with deep venous thrombosis in pediatric oncology patients: a risk model","volume":"144","author":"M Spavor","year":"2016","journal-title":"Thromb Res"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1160\/TH14-04-0372","article-title":"Haemostatic alterations induced by treatment with asparaginases and clinical consequences","volume":"113","author":"V De Stefano","year":"2015","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/17474086.2013.842124","article-title":"Thrombosis in pediatric cancer: identifying the risk factors to improve care","volume":"6","author":"U Athale","year":"2013","journal-title":"Expert Rev Hematol"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2006.06.9930","article-title":"Thromboembolic events in children and young adults with pediatric sarcoma","volume":"25","author":"I Paz-Priel","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.thromres.2024.03.009","article-title":"The role of coagulation factors VIII, IX and XI in the prediction and mediation of recurrent thrombotic events in children with non-central venous catheter deep vein thrombosis","volume":"236","author":"A Bosch","year":"2024","journal-title":"Thromb Res"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"e12763","DOI":"10.1002\/rth2.12763","article-title":"Hormonal therapies and venous thrombosis: Considerations for prevention and management","volume":"6","author":"C LaVasseur","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/jth.13913","article-title":"Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues","volume":"16","author":"F Newall","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref21","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/jth.15731","article-title":"Recommendations for standardized definitions, clinical assessment, and future research in pediatric clinically unsuspected venous thromboembolism: communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis","volume":"20","author":"M Betensky","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.chest.2021.09.019","article-title":"Acute management of high-risk and intermediate-risk pulmonary embolism in children: a review","volume":"161","author":"C Ross","year":"2022","journal-title":"Chest"},{"issue":"19","key":"ref23","first-page":"3737","article-title":"Characteristics of upper- and lower-extremity deep vein thrombosis and predictors of postthrombotic syndrome in children","volume":"5","author":"L Avila","year":"2021","journal-title":"Blood Adv"},{"issue":"06","key":"ref24","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jtha.2023.03.004","article-title":"Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis","volume":"21","author":"H Whitworth","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref25","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jpeds.2013.06.076","article-title":"Port-a-cath-related thrombosis and postthrombotic syndrome in pediatric oncology patients","volume":"163","author":"M Albisetti","year":"2013","journal-title":"J Pediatr"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1538-7836.2008.02901.x","article-title":"Prevalence of post-thrombotic syndrome following asymptomatic thrombosis in survivors of acute lymphoblastic leukemia","volume":"6","author":"S Kuhle","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"22","key":"ref27","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","article-title":"American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism","volume":"2","author":"P Monagle","year":"2018","journal-title":"Blood Adv"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"P Monagle","year":"2012","journal-title":"Chest"},{"issue":"02","key":"ref29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jama.2021.23182","article-title":"Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism: the Kids-DOTT randomized clinical trial","volume":"327","author":"N A Goldenberg","year":"2022","journal-title":"JAMA"},{"issue":"02","key":"ref30","first-page":"235","article-title":"Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study","volume":"90","author":"L Mitchell","year":"2003","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3324\/haematol.2018.194175","article-title":"THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents","volume":"104","author":"J Greiner","year":"2019","journal-title":"Haematologica"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1055\/s-0039-1697027","article-title":"Effectiveness and safety of primary thromboprophylaxis in children with cancer: a systematic review of the literature and network meta-analysis","volume":"119","author":"M C Pelland-Marcotte","year":"2019","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-0039-3400491","article-title":"Use of direct oral anticoagulants in children and adolescents","volume":"40","author":"M Albisetti","year":"2020","journal-title":"Hamostaseologie"},{"issue":"22","key":"ref34","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1182\/bloodadvances.2022008160","article-title":"Anticoagulation in pediatric cancer-associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr","volume":"6","author":"J S Palumbo","year":"2022","journal-title":"Blood Adv"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S2352-3026(20)30368-9","article-title":"Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b\/3, non-inferiority trial","volume":"8","author":"J Halton","year":"2021","journal-title":"Lancet Haematol"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S2352-3026(23)00314-9","article-title":"Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial","volume":"11","author":"S H O'Brien","year":"2024","journal-title":"Lancet Haematol"},{"issue":"S 01","key":"ref39","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood-2023-180037","article-title":"Apixaban is effective and safe in reducing venous thromboembolism (VTE) in obese patients with newly diagnosed pediatric acute lymphoblastic leukemia\/lymphoblastic lymphoma (ALL\/LL) a sub-study analysis of the Prevapix-ALL\/Children's Oncology Group ACCL1333 Trial","volume":"142","author":"V Rodriguez","year":"2023","journal-title":"Blood"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"e27483","DOI":"10.1002\/pbc.27483","article-title":"Feasibility and safety of delivering full-dose anticoagulation therapy in children treated according to Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols","volume":"66","author":"M D Bhatt","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"ref42","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"J D Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"07","key":"ref43","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/jth.12598","article-title":"Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis","volume":"12","author":"E Vidal","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12887-017-0877-x","article-title":"TropicALL study: Thromboprophylaxis in children treated for acute lymphoblastic leukemia with low-molecular-weight heparin: a multicenter randomized controlled trial","volume":"17","author":"I LM Klaassen","year":"2017","journal-title":"BMC Pediatr"},{"issue":"03","key":"ref45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood.2021013453","article-title":"Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis","volume":"139","author":"H H Clark","year":"2022","journal-title":"Blood"},{"issue":"07","key":"ref46","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood.2019000998","article-title":"Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children","volume":"135","author":"L R Brand\u00e3o","year":"2020","journal-title":"Blood"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"A A Khorana","year":"2008","journal-title":"Blood"},{"issue":"24","key":"ref48","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1182\/blood-2010-01-263012","article-title":"Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study","volume":"115","author":"L Mitchell","year":"2010","journal-title":"Blood"},{"issue":"09","key":"ref49","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.jtha.2024.05.032","article-title":"Global coagulation assays detect an early prothrombotic state in children with acute lymphoblastic leukemia","volume":"22","author":"C Betticher","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"20","key":"ref50","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1002\/cncr.34937","article-title":"Cancer-associated thrombosis and drug-drug interactions of antithrombotic and antineoplastic agents","volume":"129","author":"H Bolek","year":"2023","journal-title":"Cancer"},{"issue":"04","key":"ref51","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/jth.15260","article-title":"Subcommittee on Pediatric, Neonatal Thrombosis, Hemostasis. International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis","volume":"19","author":"C H van Ommen","year":"2021","journal-title":"J Thromb Haemost"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2407-7914.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T19:13:34Z","timestamp":1746645214000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2407-7914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":48,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2025,5,4]]},"published-print":{"date-parts":[[2025,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2407-7914","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]}}}